Showing 2861-2870 of 4960 results for "".
- Venous Thromboembolism Risk Lower in AD Patients: Analysishttps://practicaldermatology.com/news/venous-thromboembolism-risk-lower-in-ad-patients-analysis/2462196/A retrospective, observational analysis in the Journal of the American Academy of Dermatology showed that patients with atopic dermatitis (AD) do not have an increased risk for venous thromboembolism (VTE) compared with other immune-mediated inflammatory diseases. The ana
- Analysis: Vegetarian Diet during Pregnancy Lowers Risk of AD in Childrenhttps://practicaldermatology.com/news/association-between-a-maternal-vegetarian-diet-during-pregnancy-and-the-occurrence-of-atopic-dermatitis-in-children/2462188/A new study published in Pediatric Allergy and Immunology suggested that a vegetarian diet during pregnancy was associated with a reduced risk for atopic dermatitis (AD) in children. Researchers
- Skin Cancer Combination Therapy Linked with Reduced Recurrence, Death: Studyhttps://practicaldermatology.com/news/merck-moderna-detail-potential-skin-cancer-vaccine-progress/2462183/Merck and Moderna
- Nexgel Now Owns Kenkoderm Psoriasis Skincare Linehttps://practicaldermatology.com/news/nexgel-acquires-kenkoderm-psoriasis-skincare-line/2462173/NEXGEL, Inc. now owns Kenkoderm, a privately-owned skincare product company focusing on treating the symptoms of psor
- Language Barriers Linked to Underdiagnosis of Eczema and Other Allergic Conditionshttps://practicaldermatology.com/news/language-barriers-linked-to-underdiagnosis-of-eczema-and-other-allergic-conditions/2462128/
- Study: Melanoma No Longer the Leading Cause of Skin Cancer Deathshttps://practicaldermatology.com/news/study-melanoma-no-longer-the-leading-cause-of-skin-cancer-deaths/2462062/Non-melanoma skin cancer (NMSC) is causing a greater number of global deaths than melanoma, according to a new study presented at the European Academy of Dermatology and Venerology (EADV) Congress 2023 in Berlin, Germany. Researchers also believe that NMSC is underreported and that the
- Measuring ctDNA May Lead to Alternative Treatment Options and Better Outcomes in Advanced Melanomahttps://practicaldermatology.com/news/measuring-ctdna-may-lead-to-alternative-treatment-options-and-better-outcomes-in-advanced-melanoma/2462040/Circulating tumor DNA (ctDNA) is emerging as a blood-based biomarker for many solid tumor types, including melanoma. A new study found that measuring ctDNA in the blood of patients with BRAF wild-type (BRAF WT) s
- OM1 Launches HS Dataset to Expand Use of Real-World Evidence in Dermatologyhttps://practicaldermatology.com/news/om1-launches-hs-dataset-to-expand-real-world-evidence-in-dermatology/2462019/
- Exploring the Link Between Sex Hormones and Melanoma Riskhttps://practicaldermatology.com/news/exploring-the-link-between-sex-hormones-and-melanoma-risk/2462016/Researchers out of the University of Tennessee Health Science Center are beginning a study to determine whether sex hormones affect the risk of melanoma The team received a $423,500 grant from the National Institute of Environmental Health Sciences, part of the National Institutes of He
- CeraVe Launches New #ClearItUpLikeADerm Campaignhttps://practicaldermatology.com/news/cerave-launches-new-clearituplikeaderm-campaign/2461996/